Myriad Pharmaceuticals, Inc.
SEC CIK 1459450 · myrx · last insider filing 2013-03-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Scheiwe Steven D | Director | filed 2013 - 2013 |
| Pearce Michael Cooper | Director | filed 2013 - 2013 |
| Couchman Jonathan | Director · Chairman, President and CEO | filed 2013 - 2013 |
| Henderson John T | Director | filed 2009 - 2013 |
| Aryeh Jason | Director | filed 2011 - 2012 |
| Brewer Richard B | Director · President and CEO | filed 2012 - 2012 |
| Gryska David W | Director · Chief Operating Officer | filed 2012 - 2012 |
| Belle Gerald P. | Director | filed 2009 - 2012 |
| Langer Dennis | Director | filed 2009 - 2011 |
| Forrester Robert | Director | filed 2009 - 2011 |
| Franson Timothy R | Director | filed 2009 - 2011 |
| Lollini Robert J | Director · President and CEO | filed 2009 - 2011 |
| Hobden Adrian N | Director · President and CEO | filed 2009 - 2010 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kendell Andrea | Chief Financial Officer | filed 2011 - 2012 |
| Laslie W Wayne | Chief Operating Officer | filed 2009 - 2010 |
| Gibbs Andrew | Vice President, Legal | filed 2009 - 2010 |
| Berry Barbara | SVP, Human Resources | filed 2009 - 2010 |
| Swabb Edward | SVP, Drug Development, CMO | filed 2009 - 2010 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.